Extracellular phosphate-containing substrates

Extracellular phosphate-containing substrates refer to a broad class of molecules, including inorganic pyrophosphate (PPi), pyridoxal 5-phosphate (PLP), and phosphoethanolamine (PEA), which serve as the primary targets for enzymatic cleavage by alkaline phosphatases. In a clinical context, these substrates are not typically defined as a single therapeutic target but rather as the metabolic components regulated by enzymes like Tissue-Nonspecific Alkaline Phosphatase (TNSALP). For instance, in Hypophosphatasia, the deficiency of TNSALP leads to an accumulation of these extracellular substrates, which inhibits bone mineralization and causes systemic complications. Therapeutic interventions, such as enzyme replacement therapy with Asfotase alfa, aim to restore the hydrolysis of these substrates to maintain mineral homeostasis. Additionally, inorganic phosphate itself is targeted by phosphate binders in chronic kidney disease to prevent hyperphosphatemia-related vascular calcification.

Other names

Extracellular phosphosubstratesPhosphorylated metabolitesOrganic phosphates

Enzymatic hydrolysis of substrates or physical binding/sequestration to prevent absorption or promote excretion.